Endogenous activated angiotensin-(1-7) plays a protective effect against atherosclerotic plaques unstability in high fat diet fed ApoE knockout mice

International Journal of Cardiology

Volumn 184, Issue 1, 2015, Pages 645-652

  Yang, Jianmin ^a   Yang, Xiaoyan ^a   Meng, Xiao ^a   Dong, Mei ^a   Guo, Tao ^a   Kong, Jing ^a   Zhang, Kai ^a   Zhang, Yun ^a   Zhang, Cheng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Angiotensin (1 7); Atherosclerosis; Plaque stability; Renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; CHOLESTEROL; GELATINASE A; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; JANUS KINASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT PROTEIN; TRANSGELIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ANGIOTENSIN I; ANGIOTENSIN I (1-7); APOLIPOPROTEIN E; AUTACOID; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; BODY WEIGHT; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KNOCKOUT MOUSE; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ZYMOGRAPHY; ADVERSE EFFECTS; ANIMAL; DEFICIENCY; METABOLISM; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC;

ANGIOTENSIN I; ANIMALS; APOLIPOPROTEINS E; DIET, HIGH-FAT; INFLAMMATION MEDIATORS; MALE; MICE; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PLAQUE, ATHEROSCLEROTIC;

EID: 84933529883     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.059     Document Type: Article

References (23)

1. R.E. Schmieder, K.F. Hilgers, M.P. Schlaich, B.M. Schmidt, Renin-angiotensin system and cardiovascular risk, Lancet 369 (2007) 1208-1219.
2. P.K. Mehta, K.K. Griendling, Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system, Am. J. Physiol. Cell Physiol. 292 (2007) C82-C97.
3. F. Lovren, Y. Pan, A. Quan, et al., Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis, Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H1377-H1384.
4. M.J. Huentelman, J.L. Grobe, J. Vazquez, et al., Protection fromangiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats, Exp. Physiol. 90 (2005) 783-790.
5. J.C. Sluimer, J.M. Gasc, I. Hamming, et al., Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions, J. Pathol. 215 (2008) 273-279.
6. B. Dong, C. Zhang, J.B. Feng, et al., Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis, Arterioscler. Thromb. Vasc. Biol. 28 (2008) 1270-1276.
7. C. Zhang, Y.X. Zhao, Y.H. Zhang, et al., Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells, Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 15886-15891.
8. J.M. Yang, M. Dong, X. Meng, et al., Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells, Arterioscler. Thromb. Vasc. Biol. 33 (2013) 1978-1985.
9. Q. Hu, X.J. Zhang, C. Zhang, et al., Peroxisome proliferator-activated receptorgamma1 gene therapy attenuates atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice, Hum. Gene Ther. 19 (2008) 287-299.
10. B. Dong, C. Zhang, J.B. Feng, et al., Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis, Arterioscler. Thromb. Vasc. Biol. 28 (2008) 1270-1276.
11. S. Wassmann, T. Czech, M. van Eickels, I. Fleming, M. Bohm, G. Nickenig, Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice, Circulation 110 (2004) 3062-3067.
12. E. Blessing, M. Preusch, R. Kranzhofer, et al., Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice, Atherosclerosis 199 (2008) 295-303.
13. J.L. Grobe, A.P. Mecca, H. Mao, M.J. Katovich, Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension, Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H2417-H2423.
14. I.F. Benter, M.H. Yousif, C. Cojocel, M. Al-Maghrebi, D.I. Diz, Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction, Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H666-H672.
15. F. Jiang, J. Yang, Y. Zhang, et al., Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets, Nat. Rev. Cardiol. 11 (2014) 413-426.
16. H.C. Stary, A.B. Chandler, S. Glagov, et al., A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Circulation 89 (1994) 2462-2478.
17. P.K. Mehta, K.K. Griendling, Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system, Am. J. Physiol. Cell Physiol. 292 (2007) C82-C97.
18. S. Feil, F. Hofmann, R. Feil, SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis, Circ. Res. 94 (2004) 863-865.
19. G.K. Hansson, Inflammation, atherosclerosis, and coronary artery disease, N. Engl. J. Med. 352 (2005) 1685-1695.
20. L.L. Souza, C.M. Costa-Neto, Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages, J. Cell. Physiol. 227 (2012) 2117-2122.
21. F. Cipollone, M. Fazia, A. Iezzi, et al., Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2- dependent matrix metalloproteinase activity, Circulation 109 (2004) 1482-1488.
22. G. Pasterkamp, A.H. Schoneveld, D.J. Hijnen, et al., Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery, Atherosclerosis 150 (2000) 245-253.
23. C1. Silvestre-Roig, M.P. deWinther, C. Weber, M.J. Daemen, E. Lutgens, O. Soehnlein, Athersclerotic plaque destabilization: mechanisms, models, and therapeutic strategies, Circ. Res. 114 (2014) 214-226.